This announcement is a separate document:
海普瑞：(1) 建議發行公司債券 (2) 建議變更所得款項用途以及 (3) 2022年第二次臨時股東大會通告
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: (1) PROPOSED ISSUANCE OF CORPORATE BONDS (2) PROPOSED CHANGE IN USE OF PROCEEDS AND (3) NOTICE OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.